Thus, the activation of HIF-1α significantly influences the metabolic reprogramming of breast cancer cells by promoting glycolysis, enhancing survival under hypoxic conditions, supporting metastatic potential, and contributing to therapeutic resistance. The gene discussed is HIF1A; the disease is breast carcinoma.